Coherus Oncology, Inc. (CHRS)
NASDAQ·Healthcare·Biotechnology
$1.41
-1.06%
Mkt Cap $177.49M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$6.02
Range $1.05 – $11.00
Implied Upside
+328.5%
Consensus $6.02 vs current $1.41
NASDAQ·Healthcare·Biotechnology
$1.41
-1.06%
Mkt Cap $177.49M
No recent rating data.
Price Target (4 analysts)
$6.02
Range $1.05 – $11.00
+328.5%
Consensus $6.02 vs current $1.41